RecruitingNot ApplicableNCT07036692

The FaibaGo Study - Long-Term Weight Reduction Via Low-Threshold Intervention


Sponsor

University of Bern

Enrollment

120 participants

Start Date

Oct 9, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The main aim of this study is to assess the effect of a chewing gum containing galactooligosaccharides (GOS) on the body mass index (BMI), the metabolism and the oral and intestinal microbiomes in a population of overweight adults.


Eligibility

Min Age: 25 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying FibreGum and Placebo for people with nutritional and metabolic diseases and overweight. The study is currently recruiting participants at 1 location. People eligible for this study include aged 25 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTPlacebo

To chew every day during a period of 4 months 3 chewing gums (morning, noon and evening) for at least 20 minutes each.

DIETARY_SUPPLEMENTFibreGum

To chew every day during a period of 4 months 3 chewing gums (morning, noon and evening) for at least 20 minutes each.


Locations(1)

Department of Biomedical Research, University of Bern

Bern, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07036692


Related Trials